Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura Faden Garabedian, Ph.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Ross-Degnan D, Wallace J, Zhang F, Soumerai SB, Garabedian L, Wharam JF. Reduced Cost-sharing for Preventive Drugs Preferentially Benefits Low-income Patients With Diabetes in High Deductible Health Plans With Health Savings Accounts. Med Care. 2020 Jun; 58 Suppl 6 Suppl 1:S4-S13. PMID: 32412948.
    Citations:    
  2. Seidenberg AB, Garabedian LF, Gilkey MB. Trends in the number of indoor tanning facilities and tanning beds licensed in North Carolina. Prev Med Rep. 2019 Dec; 16:101013. PMID: 31890470.
    Citations:    
  3. Callahan DG, Garabedian LF, Harney KF, DiVasta AD. Will it Hurt? The Intrauterine Device Insertion Experience and Long-Term Acceptability Among Adolescents and Young Women. J Pediatr Adolesc Gynecol. 2019 Dec; 32(6):615-621. PMID: 31401254.
    Citations:    
  4. Garabedian LF, Ross-Degnan D, LeCates RF, Wharam JF. Uptake and use of a diabetes management program with a mobile glucometer. Prim Care Diabetes. 2019 12; 13(6):549-555. PMID: 31097343.
    Citations:    
  5. Sekayombya B, Nahamya D, Garabedian L, Seru M, Trap B. Inter-rater reliability and validity of good pharmacy practices measures in inspection of public sector health facility pharmacies in Uganda. J Pharm Policy Pract. 2019; 12:2. PMID: 30680220.
    Citations:    
  6. Garabedian LF, Ross-Degnan D, Wharam JF. Provider Perspectives on Quality Payment Programs Targeting Diabetes in Primary Care Settings. Popul Health Manag. 2019 06; 22(3):248-254. PMID: 30204544.
    Citations:    Fields:    
  7. Garabedian LF, Sinaiko AD, Ross-Degnan D, Abu-Jaber T, Hoefer M, Oddleifson S, Wagner AK. Quality Reporting by Payers: A Mixed-Methods Study of Provider Perspectives and Practices. Qual Manag Health Care. 2018 Jul/Sep; 27(3):157-164. PMID: 29944628.
    Citations:    Fields:    
  8. Blick B, Nakabugo S, Garabedian LF, Seru M, Trap B. Evaluating inter-rater reliability of indicators to assess performance of medicines management in health facilities in Uganda. J Pharm Policy Pract. 2018; 11:11. PMID: 29744109.
    Citations: 2     
  9. Garabedian LF, Ross-Degnan D, Soumerai SB, Choudhry NK, Brown JS. Impact of Massachusetts Health Reform on Enrollment Length and Health Care Utilization in the Unsubsidized Individual Market. Health Serv Res. 2017 06; 52(3):1118-1137. PMID: 27456334.
    Citations:    Fields:    Translation:Humans
  10. Garabedian LF, Ross-Degnan D, Wharam JF. Mobile Phone and Smartphone Technologies for Diabetes Care and Self-Management. Curr Diab Rep. 2015 Dec; 15(12):109. PMID: 26458380.
    Citations: 12     Fields:    Translation:Humans
  11. Garabedian LF, Zaslavsky AM, Soumerai SB. Instrumental variable analyses for observational comparative effectiveness research: the paired availability design. Ann Intern Med. 2014 Dec 02; 161(11):841. PMID: 25437418.
    Citations: 1     Fields:    Translation:Humans
  12. Garabedian LF, Chu P, Toh S, Zaslavsky AM, Soumerai SB. Potential bias of instrumental variable analyses for observational comparative effectiveness research. Ann Intern Med. 2014 Jul 15; 161(2):131-8. PMID: 25023252.
    Citations: 30     Fields:    Translation:Humans
  13. Leisinger KM, Garabedian LF, Wagner AK. Improving access to medicines in low and middle income countries: corporate responsibilities in context. South Med Rev. 2012 Dec; 5(2):3-8. PMID: 23535994.
    Citations: 5     
  14. Garabedian LF, Ross-Degnan D, Ratanawijitrasin S, Stephens P, Wagner AK. Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study. BMJ Open. 2012; 2(6). PMID: 23192243.
    Citations: 3     Fields:    
  15. Faden L, Soumerai SB. Comment: Assessment of Changes in Utilization of Health-Care Services After Implementation of a Prior Authorization Policy for Atypical Antipsychotic Agents. Ann Pharmacother. 2011 Feb; 45(2):283. PMID: 21304028.
    Citations:    Fields:    Translation:Humans
  16. Faden L, Vialle-Valentin C, Ross-Degnan D, Wagner A. Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence. Health Policy. 2011 May; 100(2-3):134-43. PMID: 21185616.
    Citations: 13     Fields:    Translation:Humans
  17. DiMasi JA, Faden LB. Competitiveness in follow-on drug R&D: a race or imitation? Nat Rev Drug Discov. 2011 01; 10(1):23-7. PMID: 21151030.
    Citations: 11     Fields:    Translation:Humans
  18. Cohen J, Wilson A, Faden L. Off-label use reimbursement. Food Drug Law J. 2009; 64(2):391-403. PMID: 19999289.
    Citations: 2     Fields:    Translation:Humans
  19. Cohen J, Young B, Rochon S, Faden L. Are Medicare plans complying with CMS regulation? Expert Rev Pharmacoecon Outcomes Res. 2008 Apr; 8(2):133-9. PMID: 20528402.
    Citations: 1     Fields:    
  20. Getz K, Faden L. Racial disparities among clinical research investigators. Am J Ther. 2008 Jan-Feb; 15(1):3-11. PMID: 18223347.
    Citations: 5     Fields:    Translation:Humans
  21. Faden LB, Milne CP. Pharmacovigilance activities in the United States, European Union and Japan: harmonic convergence or convergent evolution? Food Drug Law J. 2008; 63(3):683-700. PMID: 19031668.
    Citations: 4     Fields:    Translation:Humans
  22. Cohen J, Faden L, Predaris S, Young B. Patient access to pharmaceuticals: an international comparison. Eur J Health Econ. 2007 Sep; 8(3):253-66. PMID: 17279403.
    Citations: 11     Fields:    Translation:Humans
  23. Cohen J, Cairns C, Paquette C, Faden L. Comparing patient access to pharmaceuticals in the UK and US. Appl Health Econ Health Policy. 2006; 5(3):177-87. PMID: 17132032.
    Citations: 9     Fields:    Translation:Humans
  24. Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC. Monoclonal antibody successes in the clinic. Nat Biotechnol. 2005 Sep; 23(9):1073-8. PMID: 16151394.
    Citations: 136     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Garabedian's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (93)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.